See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.24▲ 0.77%
← MED page
XStocksXray
Market X-Ray report · 22 October 2026

Medartis Holding AG (MED)

SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026

Key indicators

Last closeCHF 91.70
52-week range70.60 – 97.50
Return, 1 month / 3 months+6.6% / +4.4%
Return, 1 year / 3 years+14.9% / +17.4%
TrendUptrend
RSI (14)68
Volatility (1 year)35.6%
Worst drawdown (1 year)-26.2%
Average daily value traded0.92M CHF
Dividend yield–

Market X-Ray price-based

54/ 100 · High confidence · ahead of 53% of stocks on this exchange
Trend66
Momentum61
Stability (higher is calmer)40
Liquidity46
Income–

Five-year price chart navy: price · brown: 200-day average

39.0267.1795.321231522021-102023-012024-042025-072026-10

About the company

Medartis Holding AG makes implants and surgical instruments used by surgeons to fix broken bones and correct deformities, with a focus on the hand, wrist, elbow and foot. Its plating systems and screws are designed for procedures in orthopaedic and trauma surgery, and the company supplies hospitals and specialist clinics. Medartis is based in Basel, Switzerland, and its products are used in many countries around the world.

On this site Medartis Holding AG appears as a stock on the SIX Swiss Exchange (Switzerland), code MED, with prices in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Medartis Holding AG (MED) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 91.70 on 22 October 2026.

Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 106 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 14.9% and over the last three months it rose 4.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Medartis Holding AG (MED)

The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange

Lens and metricValueScoreReading
Trend66 · FairMixed trend against its averages.
Above 200-day average8.9%
From 52-week high-5.9%
Momentum61 · FairTypical recent returns for this exchange.
3-month return4.4%
6-month return15.9%
12-month return, skipping the last month7.8%
Stability (higher is calmer)40 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)35.6%
Worst drawdown, 1 year (smaller is calmer)-26.2%
Liquidity46 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.92M CHF
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+5.4%
1 month+6.6%
3 months+4.4%
6 months+15.9%
1 year+14.9%
3 years+17.4%
5 years−23.6%

Signals

50-day / 200-day average86.39 / 84.20
Golden / death cross (60 days)Golden, 51 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.77

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026